EH
PRQR icon

Equitable Holdings’s ProQR Therapeutics PRQR Stock Holding History

Equitable Holdings’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-15,000
Closed -$101K – 855
2021
Q2 		$101K Buy
+15,000
New +$96.7K ﹤0.01% 804

Other funds holding PRQR

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Equitable Holdings's PRQR Position: Q3 2021 in Review

Equitable Holdings sold out of ProQR Therapeutics (PRQR) in Q3 2021, closing a stake of 15,000 shares — an estimated $101K sold.

Equitable Holdings first reported a position in PRQR in Q2 2021 and held it in 1 quarter. The position peaked at $101K in Q2 2021. 67 funds tracked by Wall St. Rank hold PRQR as of Q3 2021.

  • Equitable Holdings reported no remaining ProQR Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Equitable Holdings sold 15,000 ProQR Therapeutics shares in Q3 2021, an estimated $101K.
  • Equitable Holdings first reported a position in ProQR Therapeutics in Q2 2021 and held it in 1 quarter.
  • Equitable Holdings's ProQR Therapeutics position peaked at $101K in Q2 2021.
  • 67 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q3 2021.

Based on Equitable Holdings's 13F filing for Q3 2021, filed 12 Nov 2021.